Publication | Open Access
Simvastatin, an HMG-CoA reductase inhibitor, exhibits anti-metastatic and anti-tumorigenic effects in endometrial cancer
77
Citations
38
References
2014
Year
Anti-tumorigenic EffectsMedicinePharmacologyGynecologyCancer BiologyAnti-cancer AgentCancer TreatmentEndometrial CancerOncologyHmg-coa Reductase InhibitorEndocrine-related Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1